Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System after Repetitive Mild Traumatic Brain Injury.
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
White matter volume is decreased in the brain of patients with neuromyelitis optica.
CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study.
[Lyme disease in patients with multiple sclerosis: clinical, diagnostic and therapeutic features.]
Personalized Medicine in Neurodegenerative Diseases: How Far Away?
Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes.
Multiple sclerosis.
Cyclophosphamide therapy in pediatric multiple sclerosis.
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection.
Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
Reversible cerebral vasoconstriction syndrome associated with fingolimod treatment in relapsing-remitting multiple sclerosis three months after childbirth.
Natalizumab in relapsing-remitting multiple sclerosis.
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
[Side-effects of glucocorticosteroids in multiple sclerosis: a case report of a patient with global amnesia.]
Efficacy and safety of alemtuzumab in patients with relapsing-remitting multiple sclerosis who relapsed on prior therapy: Four-year follow-up of the Care-MS II study.
Please mind the gap: axonal transport deficits in multiple sclerosis neurodegeneration.
Redox regulation of NF-κB p50 and M1 polarization in microglia.
Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up.
Fine-tuning the central nervous system: microglial modelling of cells and synapses.
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.
CD44 is required for the migration of transplanted oligodendrocyte progenitor cells to focal inflammatory demyelinating lesions in the spinal cord.

Pages